158 results on '"Scheres, Luuk"'
Search Results
2. The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study
3. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial
4. Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
5. Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study
6. Concerns about the ALIFE2 trial – Authors’ reply
7. Sex matters: Practice 5P's when treating young women with venous thromboembolism
8. Endogenous sex hormones and risk of venous thromboembolism in young women
9. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy
10. Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate
11. Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism
12. Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial
13. Implementation of a clinical decision-making tool for perioperative management of vitamin K antagonists in patients with atrial fibrillation
14. Bloodcurdling movies and measures of coagulation : Fear Factor crossover trial
15. Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis: A Case-Control Study
16. Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study
17. Low-Molecular-Weight Heparin Versus Standard Pregnancy Care for Women with Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An Open-Label, Phase III Randomized Controlled Trial
18. Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia (ALIFE2): An International Open-Label, Randomised Controlled Trial.
19. Prevalence of Subclinical Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography in 45- to 55-Year-Old Women With a History of Preeclampsia
20. Global impact of World Sepsis Day on digital awareness of sepsis: an evaluation using Google Trends
21. Sex‐specific aspects of venous thromboembolism: What is new and what is next?
22. Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study
23. Antithrombotic therapy for live birth in women with recurrent pregnancy loss: do not confound available high-level evidence
24. Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - A multicentre retrospective cohort study
25. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence?
26. The relationship between DOAC levels and clinical outcomes: The measures tell the tale–Response from original authors Lijfering et al
27. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome
28. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome
29. The relationship between DOAC levels and clinical outcomes: The measures tell the tale
30. Diagnostic tests for pregnancy-related deep vein thrombosis
31. Progress of the ALIFE2 study: A dynamic road towards more evidence
32. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
33. Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?
34. Sex, hormones & clots: Sex-specific mechanisms and women-specific models for risk assessment & management in thrombosis
35. Cardiovascular risk prediction models for women in the general population : A systematic review
36. Cardiovascular risk prediction models for women in the general population: A systematic review
37. Coronary artery calcification in middle-aged women with premature ovarian insufficiency
38. Cardiovascular risk prediction models for women in the general population:A systematic review
39. Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials
40. Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis
41. Adults with osteogenesis imperfecta : Clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements
42. Adults with osteogenesis imperfecta: Clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements
43. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
44. Adults with osteogenesis imperfecta: Clinical characteristics of 151 patients with a focus on bisphosphonate use and bone density measurements
45. Current and future burden of venous thrombosis: Not simply predictable
46. Imaging for the exclusion of pulmonary embolism in pregnancy
47. Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin
48. Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome)
49. Inherited Thrombophilia and Pregnancy Loss
50. Antithrombotic therapy for live birth in women with recurrent pregnancy loss: do not confound available high-level evidence.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.